{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:37:05Z","timestamp":1770748625774,"version":"3.50.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.mam.2024.101305","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:21:37Z","timestamp":1724347297000},"page":"101305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress"],"prefix":"10.1016","volume":"99","author":[{"given":"Yuki","family":"Haga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mam.2024.101305_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.52547\/rbmb.11.4.702","article-title":"Transforming growth factor \u0392 as a marker of hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"11","author":"Abdeen Radwan","year":"2023","journal-title":"Rep Biochem Mol Biol"},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib2","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.1002\/iid3.977","article-title":"Therapeutic strategies and promising vaccine for hepatitis C virus infection","volume":"11","author":"Adugna","year":"2023","journal-title":"Immun. Inflamm Dis."},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000448077","article-title":"TNF\u03b1 augments cytokine-induced NK cell IFN\u03b3 production through TNFR2","volume":"8","author":"Almishri","year":"2016","journal-title":"J. Innate Immun."},{"issue":"14","key":"10.1016\/j.mam.2024.101305_bib4","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andr\u00e9","year":"2002","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"issue":"100","key":"10.1016\/j.mam.2024.101305_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antivir. Res."},{"issue":"115","key":"10.1016\/j.mam.2024.101305_bib7","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2024.101305_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/liv.13544","article-title":"Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV\/HIV co-infected patients with advanced fibrosis","volume":"38","author":"Beudeker","year":"2018","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.mam.2024.101305_bib10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2017.07.043","article-title":"Intra-hepatic depletion of mucosal-associated invariant T cells in hepatitis C virus-induced liver inflammation","volume":"153","author":"Bolte","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/cmi.2012.45","article-title":"Diversity of \u03b3\u03b4 T-cell antigens","volume":"10","author":"Born","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mam.2024.101305_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-023-03583-5","article-title":"These volunteers want to be infected with disease to aid research - will their altruism help?","author":"Callaway","year":"2023","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.mam.2024.101305_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215196","article-title":"The complex interplay relationship between HCV infection, direct-acting antiviral therapy, and hepatocellular carcinoma occurrence","volume":"15","author":"Cavalletto","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI126277","article-title":"Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis C virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib16","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1038\/s41467-021-25218-x","article-title":"Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib17","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1038\/s41598-019-45461-z","article-title":"Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery","volume":"9","author":"Christiansen","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.29409","article-title":"Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during hepatitis C virus infection","volume":"67","author":"Cobb","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2024.101305_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2024.101305_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15981","article-title":"Prevalence of HCV infection in europe in the DAA era: review","author":"D'Ambrosio","year":"2024","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.mam.2024.101305_bib21","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.161.5.2217","article-title":"IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells","volume":"161","author":"Dao","year":"1998","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1573409914666181003151222","article-title":"Broad spectrum peptide vaccine design against hepatitis C virus","volume":"15","author":"Dewi","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"4","key":"10.1016\/j.mam.2024.101305_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.32470","article-title":"A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice","volume":"76","author":"Donnison","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2024.101305_bib24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mam.2024.101305_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-128-10-199805150-00003","article-title":"Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation","volume":"128","author":"F\u00e9ray","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"17","key":"10.1016\/j.mam.2024.101305_bib26","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1128\/JVI.00834-07","article-title":"Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection","volume":"81","author":"Golden-Mason","year":"2007","journal-title":"J. Virol."},{"issue":"5645","key":"10.1016\/j.mam.2024.101305_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01809-23","article-title":"Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine facilitates human immune cell activation","volume":"98","author":"Haga","year":"2024","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib29","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2012.10.005","article-title":"Innate immunity and HCV","volume":"58","author":"Heim","year":"2013","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.mam.2024.101305_bib31","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/eji.201646447","article-title":"Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy","volume":"46","author":"Hengst","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","article-title":"Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection","volume":"22","author":"Hensel","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mam.2024.101305_bib33","article-title":"Diverse functions of \u03b3\u03b4 T cells in the progression of hepatitis B virus and hepatitis C virus infection","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib34","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5943","key":"10.1016\/j.mam.2024.101305_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"issue":"5740","key":"10.1016\/j.mam.2024.101305_bib36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib37","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.02474-07","article-title":"High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome","volume":"82","author":"Kasprowicz","year":"2008","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mam.2024.101305_bib39","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/hep.29843","article-title":"Hepatitis C virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages","volume":"69","author":"Kwon","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3138\/canlivj.2018.0010","article-title":"Progress toward approval of an HCV vaccine","volume":"1","author":"Law","year":"2018","journal-title":"Can Liver J."},{"issue":"2\u20133","key":"10.1016\/j.mam.2024.101305_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12026-014-8490-7","article-title":"Function of the tetraspanin molecule CD81 in B and T cells","volume":"58","author":"Levy","year":"2014","journal-title":"Immunol. Res."},{"issue":"13","key":"10.1016\/j.mam.2024.101305_bib42","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMsb2109093","article-title":"Controlled human infection model - fast track to HCV vaccine?","volume":"385","author":"Liang","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.mam.2024.101305_bib43","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1093\/cid\/ciad336","article-title":"Challenge inoculum for hepatitis C virus controlled human infection model","volume":"77","author":"Liang","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib44","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat. Med."},{"issue":"27","key":"10.1016\/j.mam.2024.101305_bib45","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.mam.2024.101305_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00055-19","article-title":"Potent anti-hepatitis C virus (HCV) T cell immune responses induced in mice vaccinated with DNA-launched RNA replicons and modified vaccinia virus ankara-HCV","volume":"93","author":"Mar\u00edn","year":"2019","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/v13010041","article-title":"Therapy implications of hepatitis C virus genetic diversity","volume":"13","author":"Martinez","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.mam.2024.101305_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00281-022-00949-1","article-title":"MAIT cells in liver inflammation and fibrosis","volume":"44","author":"Mehta","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.mam.2024.101305_bib50","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3389\/fimmu.2018.02704","article-title":"Control of the germinal center by follicular regulatory T cells during infection","volume":"9","author":"Miles","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172412","article-title":"Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus","volume":"12","author":"Miyaki","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/JLB.2MR1219-233R","article-title":"\u03b1\u03b2 and \u03b3\u03b4 T cell receptors: similar but different","volume":"107","author":"Morath","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.mam.2024.101305_bib53","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.1131929100","article-title":"Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection","volume":"100","author":"Murata","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6640","key":"10.1016\/j.mam.2024.101305_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1126\/science.adf2226","article-title":"Toward a vaccine against hepatitis C virus","volume":"380","author":"Offersgaard","year":"2023","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib55","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJMoa2023345","article-title":"Randomized trial of a vaccine regimen to prevent chronic HCV infection","volume":"384","author":"Page","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib57","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ymthe.2023.01.002","article-title":"Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population","volume":"31","author":"Patra","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-023-00635-9","article-title":"Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity","volume":"8","author":"Patra","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"12","key":"10.1016\/j.mam.2024.101305_bib59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge","volume":"20","author":"Pellicci","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"14","key":"10.1016\/j.mam.2024.101305_bib60","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.mam.2024.101305_bib61","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1128\/jvi.74.10.4824-4830.2000","article-title":"Structure-function analysis of hepatitis C virus envelope-CD81 binding","volume":"74","author":"Petracca","year":"2000","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.mam.2024.101305_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/v16050803","article-title":"Hepatitis C virus E1E2 structure, diversity, and implications for vaccine development","volume":"16","author":"Pierce","year":"2024","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.mam.2024.101305_bib64","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/jvi.68.7.4420-4426.1994","article-title":"Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus","volume":"68","author":"Ray","year":"1994","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.30214","article-title":"Hepatitis C virus manipulates humans as its favorite host for a long-term relationship","volume":"69","author":"Ray","year":"2019","journal-title":"Hepatology"},{"issue":"Suppl. 3","key":"10.1016\/j.mam.2024.101305_bib66","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/cid\/ciad382","article-title":"Ethics of controlled human infection studies with hepatitis C virus","volume":"77","author":"Rid","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"51","key":"10.1016\/j.mam.2024.101305_bib67","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7203","key":"10.1016\/j.mam.2024.101305_bib68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140590","article-title":"Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion","volume":"131","author":"Salinas","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mam.2024.101305_bib70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/hep.29346","article-title":"Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model","volume":"66","author":"Sasaki","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib71","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.29170","article-title":"Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells","volume":"66","author":"Sasaki","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.20100388","article-title":"Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence","volume":"209","author":"Schulze Zur Wiesch","year":"2012","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib73","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036988","article-title":"Innate immunity in hepatitis C virus infection","volume":"11","author":"Schwerk","year":"2021","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155432","article-title":"Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C","volume":"7","author":"Senff","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.mam.2024.101305_bib75","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/JVI.03122-12","article-title":"The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection","volume":"87","author":"Shin","year":"2013","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.mam.2024.101305_bib76","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J. Exp. Med."},{"issue":"261","key":"10.1016\/j.mam.2024.101305_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib78","article-title":"Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection","volume":"4","author":"Swadling","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mam.2024.101305_bib79","doi-asserted-by":"crossref","DOI":"10.1177\/20503121221105957","article-title":"Epidemiology, risk factors, and pathogenesis associated with a superbug: a comprehensive literature review on hepatitis C virus infection","volume":"10","author":"Tariq","year":"2022","journal-title":"SAGE Open Med."},{"issue":"2","key":"10.1016\/j.mam.2024.101305_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr. Gene Ther."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib81","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","article-title":"Failure of innate and adaptive immune responses in controlling hepatitis C virus infection","volume":"36","author":"Thimme","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"issue":"7265","key":"10.1016\/j.mam.2024.101305_bib82","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00430-014-0372-z","article-title":"Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections","volume":"204","author":"Timm","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"issue":"6617","key":"10.1016\/j.mam.2024.101305_bib84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.abn9884","article-title":"Structure of the hepatitis C virus E1E2 glycoprotein complex","volume":"378","author":"Torrents de la Pe\u00f1a","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib85","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20072195","article-title":"TLR-dependent cross talk between human Kupffer cells and NK cells","volume":"205","author":"Tu","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mam.2024.101305_bib86","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fimmu.2018.01315","article-title":"The neutralizing face of hepatitis C virus E2 envelope glycoprotein","volume":"9","author":"Tzarum","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2024.101305_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11653","article-title":"MAIT cells are activated during human viral infections","volume":"7","author":"van Wilgenburg","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mam.2024.101305_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00523-22","article-title":"Modified E2 glycoprotein of hepatitis C virus enhances proinflammatory cytokines and protective immune response","volume":"96","author":"Vijayamahantesh","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib89","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A fundamental role for interleukin-21 in the generation of T follicular helper cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib90","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells","volume":"31","author":"Wack","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mam.2024.101305_bib91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2017.03.014","article-title":"Designing an HCV vaccine: a unique convergence of prevention and therapy?","volume":"23","author":"Walker","year":"2017","journal-title":"Curr. Opin. Virol."},{"issue":"24","key":"10.1016\/j.mam.2024.101305_bib92","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2024.101305_bib93","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3389\/fimmu.2018.01436","article-title":"Hepatitis C virus (HCV)-Apolipoprotein interactions and immune evasion and their impact on HCV vaccine design","volume":"9","author":"Wrensch","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2024.101305_bib94","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.22715","article-title":"CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes","volume":"49","author":"Ye","year":"2009","journal-title":"Hepatology"},{"issue":"36","key":"10.1016\/j.mam.2024.101305_bib95","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.3748\/wjg.v13.i36.4824","article-title":"Neutralizing antibodies in hepatitis C virus infection","volume":"13","author":"Zeisel","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.mam.2024.101305_bib96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3892\/ijmm.2020.4778","article-title":"TGF-\u03b21-induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways","volume":"47","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mam.2024.101305_bib97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.intimp.2016.03.005","article-title":"Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy","volume":"34","author":"Zhang","year":"2016","journal-title":"Int. Immunopharm."},{"issue":"Suppl. 5","key":"10.1016\/j.mam.2024.101305_bib98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/1469-0691.12493","article-title":"Why is it so difficult to develop a hepatitis C virus preventive vaccine?","volume":"20","author":"Zingaretti","year":"2014","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T19:11:02Z","timestamp":1725822662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299724000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":98,"alternative-id":["S0098299724000645"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2024.101305","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2024.101305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101305"}}